by Richard Daverman, PhD
June 4, 2014 -- Baxter International officially opened a $56 million China R&D center in Suzhou Industrial Park, the company’s first R&D center in China. The Suzhou facility was charged with the mission of developing Baxter’s global R&D network further and, at the same time, providing better medical services for Chinese patients. Baxter makes both biopharmaceuticals (hemophilia and kidney treatments plus vaccines) and medical products. The company plans to split into two entities during 2015, with medical products retaining the Baxter name. More details....
Stock Symbol: (NYSE: BAX)
Help employers find you! Check out all the jobs and post your resume.
